Published: Feb, 2018

With a few leading players acquiring most of the shares, the global market for addiction treatment demonstrates a consolidated and a competitive business landscape, states a new research report by Transparency Market Research (TMR). The market is majorly led by Cipla Ltd., Alkermes plc, Allergan plc, Pfizer Inc., GlaxoSmithKiline plc, Orexo AB, Mallinckrodt, Purdue Pharma L.P, and Reckitt Benckiser. These market participants are likely to focus on innovation and technological advancements in their offerings in order to gain a competitive edge over their peers, notes the market study.

According to the research report, the global addiction treatment market offered an opportunity worth US$4.33 bn in 2016. Rising at a CAGR of 6.60% during the period from 2017 to 2025, the market is estimated to reach a value of US$7.70 bn by the end of the period of the forecast. In terms of the type of the treatment, the demand for tobacco/nicotine addiction treatment is remarkably high across the world. With the increasing number of smokers, this segment is likely to remain on the top throughout the forecast period. For similar reasons, the demand for nicotine replacement products is also projected to surge over the next few years. Europe, Asia Pacific, North America, Latin America, and the Middle East and Africa have surfaced as the main regional segments of the worldwide market for addiction treatment. Among these, North America is expected to acquire the leading position in the years to come, states the research report

global addiction treatment market

Increasing Support by Government to Drive Market’s Growth

The market for addiction treatment is witnessing a tremendous rise across the world. “The growing number of smokers and drug addicts is the main factor behind this rise,” says the author of this research study. The rising abuse of prescription drugs is also adding substantially to the growth of this market. Over the coming years, this market is likely to be driven by the increasing government support, such and rising number of initiatives to augment the awareness level of consumers regarding drug addiction and deploying favorable reimbursement policies for smoking cessation therapy. The continual introduction of innovative therapies and drugs for addiction treatment is also expected to propel this market over the next few years, reports the market study.

Lengthiness of Addiction Treatment Procedures to Hamper Market

Although the future of the worldwide addiction treatment market looks thriving, it may face several challenges in the years to come. The lengthiness of treatment procedures that need time-to-time monitoring and multiple interventions, is projected to hamper the growth trajectory of this market over the forthcoming years, states the research report.

The review is based on a report by Transparency Market Research (TMR), titled “Addiction Treatment Market (Treatment Type - Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Opioid Addiction Treatment, and Other Substance Addiction Treatment; Drug Type - Bupropion, Varenicline, Acamprosate, Disulfiram, Naltrexone, Methadone, Buprenorphine, and Nicotine Replacement Products; Treatment Centers - Outpatient Treatment Centers, Residential Treatment Centers, and Inpatient Treatment Centers; Distribution Channels - Hospital Pharmacy and Medical Stores) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025.”

Key Takeaways

  • The demand for tobacco/nicotine addiction treatment is remarkably high across the world.
  • North America is expected to acquire the leading position in the years to come.

The global addiction treatment market is segmented as follows:

By Treatment Type

  • Alcohol Addiction Treatment
  • Tobacco/Nicotine Addiction Treatment
  • Opioid Addiction Treatment
  • Other Substance Addiction Treatment

By Drug Type

  • Bupropion
  • Varenicline
  • Acamprosate
  • Disulfiram
  • Naltrexone
  • Methadone
  • Buprenorphine
  • Nicotine replacement products
  • Others surgical

By Treatment Centers

  • Outpatient Treatment Centers
  • Residential Treatment Centers
  • Inpatient Treatment Centers

By Distribution Channels

  • Hospital pharmacy
  • Medical stores
  • Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa (MEA)
    • South Africa
    • GCC Countries
    • Israel
    • Rest of MEA

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453